Europe Pharma News

top of page

iPharmaCenter

Global | Comprehensive | Patient Centric

Home
News
Regional News
Diseases
Disease News
Healthcare Policies
Conferences
COVID-19
Contact
More

Use tab to navigate through the menu items.

All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam

Search

Medicines and Healthcare products Regulatory Agency | News | 2023 Approvals | iPharmaCenter

ipharmaservices

May 16

Medicines and Healthcare products Regulatory Agency | News | 2023 Approvals | iPharmaCenter

CHMP Positive Opinions | EMA Drug Approvals | European Commission | 2023 | IPHARMACENTER

ipharmaservices

Apr 27

CHMP Positive Opinions | EMA Drug Approvals | European Commission | 2023 | IPHARMACENTER

Drug approvals in Europe| EMA drug approvals | 2023 |European Commission News| iPharmaCenter

ipharmaservices

Apr 24

Drug approvals in Europe| EMA drug approvals | 2023 |European Commission News| iPharmaCenter

NICE ASSESSMENT OUTCOMES | 2023 United Kingdom | Healthcare | Pharma | News | Blogs | iPharmaCenter

ipharmaservices

Apr 6

NICE ASSESSMENT OUTCOMES | 2023 United Kingdom | Healthcare | Pharma | News | Blogs | iPharmaCenter

HAS ASSESSMENT OUTCOMES | FRANCE PHARMA NEWS | médicament nouvelles | 2023 | iPharmaCenter

ipharmaservices

Mar 12

HAS ASSESSMENT OUTCOMES | FRANCE PHARMA NEWS | médicament nouvelles | 2023 | iPharmaCenter

2022 | CHMP Positive Opinions | EMA Drug Approvals | European Commission | Pharma | News

ipharmaservices

Feb 28

2022 | CHMP Positive Opinions | EMA Drug Approvals | European Commission | Pharma | News

Drug approvals in Europe| EMA drug approvals in 2022 |European Commission News| iPharmaCenter

ipharmaservices

Jan 26

Drug approvals in Europe| EMA drug approvals in 2022 |European Commission News| iPharmaCenter

France healthcare News | HAS Sante | COVID 19 | Drug approvals | iPharmaCenter

ipharmaservices

Jan 6

France healthcare News | HAS Sante | COVID 19 | Drug approvals | iPharmaCenter

COVID19 drug updates | FDA EMA approved COVID19 drugs

ipharmaservices

Oct 9, 2022

COVID19 drug updates | FDA EMA approved COVID19 drugs

ipharmaservices

Sep 19, 2022

Opdualag was approved for unresectable/metastatic melanoma | LAG-3 inhibitors | Mode of action

European Commission approved Scemblix for chronic myeloid leukemia | iPharmaCenter

ipharmaservices

Aug 29, 2022

European Commission approved Scemblix for chronic myeloid leukemia | iPharmaCenter

Roche’s Polivy was approved as first-line therapy for patients with DLBCL.

ipharmaservices

May 25, 2022

Roche’s Polivy was approved as first-line therapy for patients with DLBCL.

FDA gave the nod to Pfizer's Paxlovid | Pfizer to supply 2.5 million doses of Paxlovid to the UK

ipharmaservices

Dec 23, 2021

FDA gave the nod to Pfizer's Paxlovid | Pfizer to supply 2.5 million doses of Paxlovid to the UK

Germany HTA News | IQWIG and G-BA assessment news | Germany Pharma News

ipharmaservices

Dec 9, 2021

Germany HTA News | IQWIG and G-BA assessment news | Germany Pharma News

European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

ipharmaservices

Nov 21, 2021

European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

NHS England News | NHS to offer Tagrisso for lung cancer patients

ipharmaservices

May 12, 2021

NHS England News | NHS to offer Tagrisso for lung cancer patients

United Kingdom COVID19 News | Has Britain reached herd immunity?

ipharmaservices

May 11, 2021

United Kingdom COVID19 News | Has Britain reached herd immunity?

European Commission approved Benlysta for active lupus nephritis

ipharmaservices

May 9, 2021

European Commission approved Benlysta for active lupus nephritis

France COVID-19 Updates | COVID-19 News in Europe

ipharmaservices

May 4, 2021

France COVID-19 Updates | COVID-19 News in Europe

GSK’s Jemperli received approval in Europe and the US for endometrial cancer

ipharmaservices

Apr 23, 2021

GSK’s Jemperli received approval in Europe and the US for endometrial cancer

1

2 3

For sponsored articles and advertisements, please write to ipharmaservices@gmail.com

Healthcare Policies

©2022 by ipharmaservices

iPharmaCenter

bottom of page